Fibroblast growth factor 21 facilitates peripheral nerve regeneration through suppressing oxidative damage and autophagic cell death. Issue 1 (18th November 2018)

• Record Type: Journal Article
• Authors: Lu, Yingfeng; Li, Rui; Zhu, Junyi; Wu, Yanqing; Li, Duohui; Dong, Lupeng; Li, Yiyang; Wen, Xin; Yu, Fangzheng; Zhang, Hongyu; Ni, Xiao; Du, Shenghu; Li, Xiaokun; Xiao, Jian; Wang, Jian
• Is Part Of: Journal of cellular and molecular medicine. Volume 23:Issue 1(2019)
• Page Start: 497
• Page End: 511
• Publication Date: 2018-11-18
• Subjects: autophagic cell death -- fibroblast growth factor 21 -- oxidative stress -- peripheral nerve injury -- remyelination; Cytology; Medicine; Molecular Biology; Cytologie -- Périodiques; Médecine -- Périodiques; Biologie moléculaire -- Périodiques; Cytology -- Periodicals; Medicine -- Periodicals; Molecular biology -- Periodicals; 611.01805
• DOI: 10.1111/jcmm.13952
• Languages: English
• ISSNs: 1582-1838

Abstract

Abstract: Seeking for effective drugs which are beneficial to facilitating axonal regrowth and elongation after peripheral nerve injury (PNI) has gained extensive attention. Fibroblast growth factor 21 (FGF21) is a metabolic factor that regulates blood glucose and lipid homeostasis. However, there is little concern for the potential protective effect of FGF21 on nerve regeneration after PNI and revealing related molecular mechanisms. Here, we firstly found that exogenous FGF21 administration remarkably promoted functional and morphologic recovery in a rat model of sciatic crush injury, manifesting as persistently improved motor and sensory function, enhanced axonal remyelination and regrowth and accelerated Schwann cells (SCs) proliferation. Furthermore, local FGF21 application attenuated the excessive activation of oxidative stress, which was accompanied with the activation of nuclear factor erythroid‐2‐related factor 2 (Nrf‐2) transcription and extracellular regulated protein kinases (ERK) phosphorylation. We detected FGF21 also suppressed autophagic cell death in SCs. Additionally, treatment with the ERK inhibitor U0126 or autophagy inhibitor 3‐MA partially abolishes anti‐oxidant effect and reduces SCs death. Taken together, these results indicated that the role of FGF21 in remyelination and nerve regeneration after PNI was probably related to inhibit the excessive activation of ERK/Nrf‐2 signalling‐regulated oxidative stress and autophagy‐induced cell death. Overall, our work suggests that FGF21 administration may provide a new therapy for PNI.